查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1717101

體外二氧化碳去除裝置市場（按產品類型、存取、操作模式、應用和最終用戶）—2025-2030 年全球預測

Extracorporeal CO2 Removal Devices Market by Product Types, Access, Mode of Operation, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

體外二氧化碳去除裝置市場預計在 2024 年達到 1.4755 億美元，在 2025 年成長至 1.5968 億美元，到 2030 年達到 2.4018 億美元，複合年成長率為 8.45%。

主要市場統計數據
基準年2024年 1.4755億美元
預計2025年 1.5968億美元
預測年份 2030 2.4018億美元
複合年成長率（%） 8.45%

體外二氧化碳去除裝置已成為現代呼吸護理的重要解決方案，為患有嚴重肺部疾病的患者提供了策略選擇。近年來，這項技術經歷了重大創新和改進，改變了臨床醫生處理呼吸窘迫的方式。急性呼吸窘迫症候群(ARDS)、慢性阻塞性肺病(COPD) 等疾病的盛行率不斷上升，以及對肺移植橋樑的需求不斷成長，都促進了充滿活力且競爭激烈的市場的擴張。

該領域的進步不僅限於單純的技術進步，還包括整合複雜的設計功能和增強的安全通訊協定。在尖端研發的支持下，這些設備提高了氣體交換過程的效率，同時最大限度地降低了體外治療固有的風險。推動自動化和簡化流程也減少了對人工干預的依賴，提高了可靠性和病人安全性。

此外，跨學科合作在該領域發揮著至關重要的作用。創新源於工程、臨床專業知識和強大的數據分析的交叉。相關人員發現，這種有凝聚力的方法不僅加速了產品開發，而且還使技術性能與不斷變化的臨床需求保持一致。因此，這個市場不僅代表著成長的機會，也代表著重新定義患者照護標準的機會。該報告詳細回顧了影響市場的新興趨勢、關鍵細分見解和變革性變化，最終成為行業領導者和決策者的重要指南。

體外二氧化碳去除裝置格局的變革時期

該行業已經經歷了幾次變革，正在重塑外部二氧化碳去除技術的格局。材料科學和生物醫學工程的進步使製造商能夠最佳化設備性能，從而實現更有效的氣體交換並降低併發症率。自動化一直是技術進步的主要驅動力，改進的電腦控制和即時監控系統使醫療保健專業人員能夠更精確地執行複雜的流程。

經濟變化也發揮了作用，成本效益的驅動迫使醫療保健提供者採用能夠提供高性能和永續營運的創新。此外，對以患者為中心的護理的日益重視促進了設備的發展，這些設備不僅更高效，而且侵入性更小，從而顯著改善了患者的治療效果和長期治療期間的舒適度。新興技術、經濟和患者照護優先事項的結合正在推動市場擺脫傳統模式並採用下一代解決方案。

監管變化也是一個關鍵因素，因為更嚴格的安全性和有效性標準要求製造商不斷改進其產品。產業相關人員、學術機構和臨床專家之間加強合作有助於更豐富、更全面地了解患者需求和治療反應。同時，新興的數據分析和數位健康應用正在發揮支援作用，提供可行的見解，為設計改進和臨床決策提供資訊。這種轉變正在為性能和效率樹立新的標桿，為持續創新和市場擴張鋪平道路。

關鍵市場區隔洞察

體外二氧化碳去除的市場細分提供了對不同動態的細緻理解。基於產品類型的細分尤為明顯，突出了設備從傳統 ECCO2R 設備到先進的膜式氧合器和複雜的滾壓泵系統的演變。同時，基於通路的分割區分兩種主要方法：動脈和靜脈。每種方法都代表了針對患者和血流動力學管理的截然不同的方法論。

當考慮操作模式時，自動系統和手動系統之間有明顯的對比。這種差異凸顯了人們對自動化日益成長的偏好，這有助於降低操作複雜性並提高整體效能。此外，將重點轉移到應用上，市場具有不同的使用模式，例如管理急性呼吸窘迫症候群、肺移植橋接以及管理慢性阻塞性肺病。這些應用將進一步決定治療策略並影響設備設計。

最後，按最終用戶細分，凸顯了不同醫療保健環境（從門診手術中心和居家醫療機構到醫院和專科診所）的需求變化。每個部分都對區域差異、臨床要求和潛在技術採用提供了獨特的見解。這些細分參數的交集描繪出一幅全面的整體情況，將指南製造商和政策制定者制定策略以滿足當前和未來的市場需求。

目錄

第1章 引言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章 市場洞察

  • 市場動態
    • 驅動程式
      • 急性呼吸衰竭、嚴重氣喘及慢性阻塞性肺病盛行率上升
      • 醫療保健專業人士對非侵入式二氧化碳去除解決方案的認知日益提高
      • 擴大醫療基礎設施並增加人均支出
    • 限制因素
      • 與 ECCO2R 系統運作相關的技術整合風險；
    • 機會
      • 增加體外二氧化碳去除裝置技術進步的研究、開發與資金投入
      • 增加監管產品核可和設備臨床試驗
    • 任務
      • 管理供應鏈的複雜性並確保遠距醫療站點的設備可用性
  • 市場區隔分析
    • 產品類型：增加使用 ECCO2R 設備進行體外二氧化碳移除以治療嚴重肺部併發症
    • 應用：急性呼吸窘迫症候群裝置在體外二氧化碳移除裝置的擴展應用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社會
    • 技術的
    • 合法的
    • 環境

6. 外部二氧化碳去除裝置市場（依產品類型）

  • ECCO2R機器
  • 膜式氧合器
  • 滾壓泵

7. 外部二氧化碳去除設備市場進入）

  • 動脈和靜脈
  • 靜脈

8. 體外二氧化碳去除裝置市場（依操作模式）

  • 自動化系統
  • 手動系統

第9章體外二氧化碳去除裝置市場：依應用

  • 急性呼吸窘迫症候群
  • 肺移植的橋樑
  • 慢性阻塞性肺病

第 10 章。體外二氧化碳去除裝置市場（依最終用戶分類）

  • 門診手術中心
  • 居家照護環境
  • 醫院
  • 專科診所

第 11 章美洲體外二氧化碳移除裝置市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

12.亞太地區體外二氧化碳去除裝置市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

13. 歐洲、中東和非洲體外二氧化碳去除裝置市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2024年市場佔有率分析
  • 2024年FPNV定位矩陣
  • 競爭情境分析
  • 戰略分析與建議

公司名單

  • Aferetica Srl
  • ALung Technologies, Inc. by LivaNova PLC
  • Baxter International Inc.
  • Dragerwerk AG & Co. KGaA
  • Edwards Lifesciences Corporation
  • Estor SpA
  • Fresenius Medical Care AG
  • Getinge AB
  • Inspira-Technologies OXY BHN LTD
  • Koninklijke Philips NV
  • LivaNova PLC
  • Medica SpA
  • MicroPort Scientific Corporation
  • Nikkiso Co., Ltd.
  • NovaLung GmbH
  • Terumo Corporation
  • X-COR Therapeutics
  • XENIOS AG by Fresenius Medical Care AG & Co. KGaA
Product Code: MRR-F927BA462E0F

The Extracorporeal CO2 Removal Devices Market was valued at USD 147.55 million in 2024 and is projected to grow to USD 159.68 million in 2025, with a CAGR of 8.45%, reaching USD 240.18 million by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 147.55 million
Estimated Year [2025] USD 159.68 million
Forecast Year [2030] USD 240.18 million
CAGR (%) 8.45%

Extracorporeal CO2 Removal Devices have emerged as a critical solution in modern respiratory care, offering a strategic alternative for patients suffering from severe pulmonary conditions. In recent years, this technology has experienced significant innovations and improvements, transforming the way clinicians manage respiratory distress. The increasing prevalence of conditions such as Acute Respiratory Distress Syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD), and the rising demand to bridge to lung transplant have all contributed to an expanding market that is both dynamic and highly competitive.

The evolution in this space is not confined merely to technological advancements but extends to the integration of sophisticated design features and enhanced safety protocols. Underpinned by cutting-edge research and development, these devices have achieved improved efficiency in gas exchange processes while minimizing the inherent risks associated with extracorporeal therapies. The drive towards automation and streamlined processes has also reduced the dependency on manual intervention, thereby bolstering both reliability and patient safety.

Furthermore, the role of interdisciplinary collaboration in this sector has been pivotal. Innovations are emerging from an amalgamation of engineering, clinical expertise, and robust data analytics. Stakeholders are finding that this cohesive approach not only accelerates product development but also aligns the technical performance with the evolving clinical needs. As such, the market presents not just an opportunity for growth but also a chance to redefine patient care standards. This report provides an in-depth review of the rising trends, key segmentation insights, and the transformative shifts impacting the market, ultimately serving as an essential guide for industry leaders and decision-makers.

Transformative Shifts in the Landscape of Extracorporeal CO2 Removal Devices

The industry has witnessed several transformative shifts that are reshaping the landscape of extracorporeal CO2 removal technologies. Advances in material sciences and biomedical engineering have allowed manufacturers to optimize device performance, leading to more efficient gas exchange and reduced complication rates. The technological progression is largely driven by an increasing focus on automation, where enhanced computerized controls and real-time monitoring systems empower healthcare professionals to execute complex processes with improved precision.

Economic shifts have also played a role, as the drive for cost-effectiveness pressures providers to adopt innovations that deliver both high performance and sustainable operation. Moreover, the growing emphasis on patient-centered care has catalyzed the development of devices that are not only efficient but also minimally invasive, which significantly improves patient outcomes and comfort during extended therapies. This synthesis of advanced technology, economic prudence, and patient care priorities is driving the market to move away from traditional paradigms and embrace next-generation solutions.

Regulatory changes are another critical factor, with stringent safety and efficacy standards compelling manufacturers to continually refine their product offerings. Increased collaboration between industry players, academic institutions, and clinical experts is fostering a richer, more comprehensive understanding of patient needs and treatment responses. In parallel, emerging data analytics and digital health applications are playing a supplementary role by providing actionable insights that inform both design improvements and clinical decision-making. Such shifts have established a new benchmark for performance and efficiency, carving out a path for sustained innovation and market expansion.

Key Insights into Market Segmentation

Market segmentation within the extracorporeal CO2 removal landscape offers a nuanced understanding of the diverse dynamics at play. The segmentation based on product types is particularly revealing, as it highlights the evolution of devices from traditional ECCO2R machines to advanced membrane oxygenators and sophisticated roller pump systems. In parallel, the segmentation based on access delineates two principal approaches: arteriovenous and venovenous. Each modality represents substantially different methodologies in patient management and hemodynamic control.

Further differentiation is seen when examining the mode of operation, where a distinct contrast exists between automated systems and manual systems. This delineation underscores the growing preference for automation, which has been instrumental in reducing operational complexities and enhancing overall performance. Additionally, when the focus shifts to applications, the market clearly characterizes distinct usage patterns, such as addressing Acute Respiratory Distress Syndrome, providing a bridge to lung transplant, and managing Chronic Obstructive Pulmonary Disease. These applications further dictate the therapeutic strategies and impact the design of devices.

Lastly, segmentation by end user surfaces variations in demand across different care settings, ranging from ambulatory surgical centers and home care settings to hospitals and specialty clinics. Each of these segments provides unique insights concerning regional disparities, clinical requirements, and potential for technological adoption. The intersection of these segmentation parameters paints a comprehensive picture that guides manufacturers and policy makers in tailoring their strategies to meet both current and future market needs.

Based on Product Types, market is studied across ECCO2R Machines, Membrane Oxygenators, and Roller pump.

Based on Access, market is studied across Arteriovenous and Venovenous.

Based on Mode of Operation, market is studied across Automated Systems and Manual Systems.

Based on Application, market is studied across Acute Respiratory Distress Syndrome, Bridge to Lung Transplant, and Chronic Obstructive Pulmonary Disease.

Based on End User, market is studied across Ambulatory Surgical Centers, Home Care Settings, Hospitals, and Specialty Clinics.

Significant Regional Insights Shaping the Market

The global landscape for extracorporeal CO2 removal devices reveals considerable regional variations, each contributing distinctively to the overall growth trajectory. In the Americas, the market is characterized by robust healthcare infrastructure and widespread adoption of advanced medical technologies. This region's dynamic regulatory environment and strong emphasis on patient outcomes foster a conducive setting for both established companies and emerging players to invest in innovative solutions.

Across Europe, the Middle East, and Africa, market dynamics are influenced by a confluence of high clinical demand coupled with strategic governmental initiatives. Advanced healthcare systems, in tandem with active research and collaboration networks, are generating significant interest in devices that offer improved safety profiles and operational simplicity. This region's challenges often spur innovative solutions tailored to meet the dual demands of efficacy and cost efficiency.

In Asia-Pacific, rapid economic development and expanding healthcare access are driving market growth. The region combines a high volume of patient populations with an increasing number of private and public healthcare institutions. With a keen interest in incorporating breakthrough healthcare technologies, this market is witnessing accelerated innovations, particularly in terms of integrating automation and digital solutions into device operations. Together, these regional insights underscore a landscape defined by varied clinical practices, economic drivers, and regulatory frameworks, each contributing uniquely to the overall evolution of the market.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Competitive Landscape and Key Company Insights

A highly competitive environment characterizes the emerging market of extracorporeal CO2 removal devices, where several leading companies are driving forward critical innovations. Industry leaders such as Aferetica Srl, ALung Technologies, Inc. by LivaNova PLC, Baxter International Inc., and Dragerwerk AG & Co. KGaA are at the forefront of advancing product capabilities and refining design protocols. At the same time, Edwards Lifesciences Corporation, Estor S.p.A, and Fresenius Medical Care AG have established themselves as key players by focusing on rigorous clinical validations and robust quality standards.

Not far behind are Getinge AB, Inspira-Technologies OXY B.H.N. LTD, and Koninklijke Philips N.V., each contributing uniquely to the technological ecosystem through collaborative research and targeted development projects. Prominent entities such as LivaNova PLC, Medica S.p.A, and MicroPort Scientific Corporation further underscore the sector's dynamism by consistently pushing the envelope on performance enhancements and usability. These companies are complemented by the pioneering efforts of Nikkiso Co., Ltd., NovaLung GmbH, and Terumo Corporation, which have all implemented strategies ranging from strategic partnerships to comprehensive global market deployment.

Other notable contributors include X-COR Therapeutics and XENIOS AG by Fresenius Medical Care AG & Co. KGaA, whose continued commitment to innovation and excellence has helped fortify market positions and drive industry-wide standards. By leveraging advanced research, adaptive manufacturing processes, and expansive clinical networks, these companies have not only set new benchmarks in device efficacy but have also effectively shaped industry trends. Their collective efforts are ensuring that extracorporeal CO2 removal technology remains at the cutting edge of respiratory care solutions.

The report delves into recent significant developments in the Extracorporeal CO2 Removal Devices Market, highlighting leading vendors and their innovative profiles. These include Aferetica Srl, ALung Technologies, Inc. by LivaNova PLC, Baxter International Inc., Dragerwerk AG & Co. KGaA, Edwards Lifesciences Corporation, Estor S.p.A, Fresenius Medical Care AG, Getinge AB, Inspira-Technologies OXY B.H.N. LTD, Koninklijke Philips N.V., LivaNova PLC, Medica S.p.A, MicroPort Scientific Corporation, Nikkiso Co., Ltd., NovaLung GmbH, Terumo Corporation, X-COR Therapeutics, and XENIOS AG by Fresenius Medical Care AG & Co. KGaA. Actionable Recommendations for Industry Leaders

Industry leaders should consider a strategic roadmap that embraces both innovation and operational efficiency to remain competitive in the evolving market of extracorporeal CO2 removal devices. It is recommended that companies invest in robust research and development programs to harness the benefits of automation and digital integration, which have been shown to enhance device reliability and patient safety. By focusing on continuous improvement in performance, companies can address the growing clinical needs effectively and maintain regulatory compliance.

Moreover, a diversified market approach that leverages insights from key segmentations-ranging from product type and access method to mode of operation, application, and end-user preferences-is essential. Organizations need to capitalize on the data-driven trends that point to the rising demand for automated systems and minimally invasive technologies. Building strategic alliances with clinical experts and academic institutions can further aid in refining design specifications and fast-tracking product innovation.

Navigating regional differences by tailoring solutions to meet specific market demands is crucial. Companies should adopt targeted marketing strategies in regions such as the Americas, Europe, Middle East & Africa, and Asia-Pacific, while remaining agile in response to evolving local regulatory frameworks. Embracing a customer-centric approach, with a focus on post-market surveillance and real-time feedback, will enable continuous enhancements and foster greater consumer trust. In summary, a balanced investment in technology, collaboration, and regional market intelligence will help solidify long-term competitive advantages.

Conclusion: A Future Poised for Innovation and Growth

In conclusion, the landscape of extracorporeal CO2 removal devices is undergoing significant transformation, driven by technological advancements, diversified market segmentations, and dynamic regional trends. The evolution from traditional solutions to more automated, efficient, and patient-friendly systems underscores the significant progress made in the field. With heightened regulatory scrutiny and the ongoing commitment of leading companies towards innovation, the industry is positioned for robust growth.

This comprehensive analysis reveals that harnessing the potential of emerging technologies while recognizing the unique clinical demands across regions is key to sustaining success. Industry stakeholders are well-advised to leverage actionable insights derived from market segmentation and regional analyses. With strategic investments and collaborative efforts, the market can achieve unprecedented levels of performance and efficiency, ultimately redefining standards in respiratory care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of acute respiratory failure, severe asthma, and COPD
      • 5.1.1.2. Growing awareness among healthcare professionals about non-invasive CO2 removal solutions
      • 5.1.1.3. Increasing healthcare infrastructure and rise in per capita expenditure
    • 5.1.2. Restraints
      • 5.1.2.1. Technical integration risk associated with operating ECCO2R systems
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising R&D and funding for technological advancements in extracorporeal CO2 removal devices
      • 5.1.3.2. Increasing regulatory product approval and clinical trials for the device
    • 5.1.4. Challenges
      • 5.1.4.1. Managing supply chain complexities and ensuring device availability in remote healthcare settings
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product Types: Growing usage of ECCO2R machines in extracorporeal CO2 removal to treat severe pulmonary complications
    • 5.2.2. Application: Expanding application of Acute respiratory distress syndrome devices in extracorporeal CO2 removal devices
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Extracorporeal CO2 Removal Devices Market, by Product Types

  • 6.1. Introduction
  • 6.2. ECCO2R Machines
  • 6.3. Membrane Oxygenators
  • 6.4. Roller pump

7. Extracorporeal CO2 Removal Devices Market, by Access

  • 7.1. Introduction
  • 7.2. Arteriovenous
  • 7.3. Venovenous

8. Extracorporeal CO2 Removal Devices Market, by Mode of Operation

  • 8.1. Introduction
  • 8.2. Automated Systems
  • 8.3. Manual Systems

9. Extracorporeal CO2 Removal Devices Market, by Application

  • 9.1. Introduction
  • 9.2. Acute Respiratory Distress Syndrome
  • 9.3. Bridge to Lung Transplant
  • 9.4. Chronic Obstructive Pulmonary Disease

10. Extracorporeal CO2 Removal Devices Market, by End User

  • 10.1. Introduction
  • 10.2. Ambulatory Surgical Centers
  • 10.3. Home Care Settings
  • 10.4. Hospitals
  • 10.5. Specialty Clinics

11. Americas Extracorporeal CO2 Removal Devices Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Extracorporeal CO2 Removal Devices Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Extracorporeal CO2 Removal Devices Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Inspira Technologies enhances its INSPIRA ART100 system with advanced alarm troubleshooting and automated critical care guidance
    • 14.3.2. NSW launches mobile ECMO referral service that deploys specialist pediatric teams for immediate lifesaving care
    • 14.3.3. The ROMEO trial secured GBP 2.1 million in NIHR funding
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Aferetica Srl
  • 2. ALung Technologies, Inc. by LivaNova PLC
  • 3. Baxter International Inc.
  • 4. Dragerwerk AG & Co. KGaA
  • 5. Edwards Lifesciences Corporation
  • 6. Estor S.p.A
  • 7. Fresenius Medical Care AG
  • 8. Getinge AB
  • 9. Inspira-Technologies OXY B.H.N. LTD
  • 10. Koninklijke Philips N.V.
  • 11. LivaNova PLC
  • 12. Medica S.p.A
  • 13. MicroPort Scientific Corporation
  • 14. Nikkiso Co., Ltd.
  • 15. NovaLung GmbH
  • 16. Terumo Corporation
  • 17. X-COR Therapeutics
  • 18. XENIOS AG by Fresenius Medical Care AG & Co. KGaA

LIST OF FIGURES

  • FIGURE 1. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET MULTI-CURRENCY
  • FIGURE 2. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET MULTI-LANGUAGE
  • FIGURE 3. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET RESEARCH PROCESS
  • FIGURE 4. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 17. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 19. AMERICAS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 21. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 26. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 27. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ECCO2R MACHINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MEMBRANE OXYGENATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ROLLER PUMP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ARTERIOVENOUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY VENOVENOUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY AUTOMATED SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MANUAL SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACUTE RESPIRATORY DISTRESS SYNDROME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY BRIDGE TO LUNG TRANSPLANT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 235. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • TABLE 236. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, FPNV POSITIONING MATRIX, 2024